The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in ...

According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...